NCT00375934View on ClinicalTrials.gov

Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

January 31, 2007

Conditions

Pain, Postoperative

Interventions

DRUG

diclofenac potassium (XP21L)

25 mg capsule, every 6 hours

DRUG

Placebo

Oral placebo capsule, every 6 hours

Trial Locations (4)

77057

Investigative Site, Houston

78666

Investigative Site, San Marcos

78705

Investigative Site, Austin

84117

Investigative Site, Salt Lake City

All Listed Sponsors

lead

Xanodyne Pharmaceuticals

INDUSTRY

NCT00375934 - Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery | Biotech Hunter | Biotech Hunter